Fibrinogen-Albumin Ratio Index (FARI) as a Certain Prognostic Biomarker in Pretreated Patients with Immunotherapy.

Cancer Manag Res · 2021 · PMC8163584 · PMID 34079370

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

did not achieve significancep =0.08so close (0.05 < p ≤ 0.1)

Meanwhile, the PFS did not achieve significance in the two FARI groups ( p =0.08) ( Figure 4A ).

also in 1,397 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.